Smith CH - Search Results

1

Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes.

Setta-Kaffetzi N, Navarini AA, Patel VM, Pullabhatla V, Pink AE, Choon SE, Allen MA, Burden AD, Griffiths CE, Seyger MM, Kirby B, Trembath RC, Simpson MA, Smith CH, Capon F, Barker JN. Setta-Kaffetzi N, et al. Among authors: smith ch. J Invest Dermatol. 2013 May;133(5):1366-9. doi: 10.1038/jid.2012.490. Epub 2013 Jan 10. J Invest Dermatol. 2013. PMID: 23303454 Free article. No abstract available.

2

Adhesion molecules in allergic inflammation.

Smith CH, Barker JN, Lee TH. Smith CH, et al. Am Rev Respir Dis. 1993 Dec;148(6 Pt 2):S75-8. doi: 10.1164/ajrccm/148.6_Pt_2.S75. Am Rev Respir Dis. 1993. PMID: 7504897 Review.

3

Cell trafficking and role of adhesion molecules in psoriasis.

Smith CH, Barker JN. Smith CH, et al. Clin Dermatol. 1995 Mar-Apr;13(2):151-60. doi: 10.1016/0738-081x(95)93821-5. Clin Dermatol. 1995. PMID: 7780917 Review. No abstract available.

4

Diffuse plane xanthomatosis and acquired palmoplantar keratoderma in association with myeloma.

Smith CH, Barker JN, Hay RJ. Smith CH, et al. Br J Dermatol. 1995 Feb;132(2):286-9. doi: 10.1111/j.1365-2133.1995.tb05029.x. Br J Dermatol. 1995. PMID: 7888370

5

A case of chromoblastomycosis responding to treatment with itraconazole.

Smith CH, Barker JN, Hay RJ. Smith CH, et al. Br J Dermatol. 1993 Apr;128(4):436-9. doi: 10.1111/j.1365-2133.1993.tb00205.x. Br J Dermatol. 1993. PMID: 8388236

6

Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects.

Smith CH, Allen MH, Groves RW, Barker JN. Smith CH, et al. Br J Dermatol. 1998 Aug;139(2):239-46. doi: 10.1046/j.1365-2133.1998.02360.x. Br J Dermatol. 1998. PMID: 9767237

7

A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis.

Smith CH, Jackson K, Chinn S, Angus K, Barker JN. Smith CH, et al. Clin Exp Dermatol. 2000 Nov;25(8):580-3. doi: 10.1046/j.1365-2230.2000.00710.x. Clin Exp Dermatol. 2000. PMID: 11167965 Clinical Trial.

8

Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.

Chew AL, Bennett A, Smith CH, Barker J, Kirkham B. Chew AL, et al. Among authors: smith ch. Br J Dermatol. 2004 Aug;151(2):492-6. doi: 10.1111/j.1365-2133.2004.06105.x. Br J Dermatol. 2004. PMID: 15327561

9

British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005.

Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler D, Finlay AY, Griffiths CE, Jackson K, McHugh NJ, McKenna KE, Reynolds NJ, Ormerod AD; British Association of Dermatologists. Smith CH, et al. Br J Dermatol. 2005 Sep;153(3):486-97. doi: 10.1111/j.1365-2133.2005.06893.x. Br J Dermatol. 2005. PMID: 16120132 No abstract available.

10

Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis.

Young HS, Summers AM, Read IR, Fairhurst DA, Plant DJ, Campalani E, Smith CH, Barker JN, Detmar MJ, Brenchley PE, Griffiths CE. Young HS, et al. Among authors: smith ch. J Invest Dermatol. 2006 Feb;126(2):453-9. doi: 10.1038/sj.jid.5700096. J Invest Dermatol. 2006. PMID: 16385345 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

660 results

Search Page